<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:"Calibri","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoPlainText">Sorry I’m no help with the cytotoxic chemotheraphy drug contamination issue but in slide #10 in the presentation to Senator Whitehouse sent in the previous e-mail and copied below, I’m curious where exactly the text quantifying drug
disposal destinations comes from that references Dr. Daughton’s <a href="http://www.google.com/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CCcQFjAA&url=http%3A%2F%2Fwww.epa.gov%2Fnerlesd1%2Fbios%2Fdaughton%2FAPM200-2010.pdf&ei=vOUFT9umM9TYiQL63a2ADA&usg=AFQjCNFTZeyhoeFcsW0n1nKOu1v_szj1nw&sig2=KwP3kkclw66rGI8tyzN9-w">
Drugs and the Environment: Stewardship & Sustainability</a> report. I was only able to find this on pages 17-18: "The question as to what fraction of collective or individual API residues in the aquatic environment emanates from direct disposal versus excretion
and bathing is currently not answerable."<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><img border="0" width="632" height="421" id="Picture_x0020_1" src="cid:image003.jpg@01CCCB98.C9B96620"><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Burke Lucy<o:p></o:p></p>
<p class="MsoNormal">Integrated Waste Management Specialist<o:p></o:p></p>
<p class="MsoNormal">Department of Resources Recycling and Recovery (CalRecycle)<o:p></o:p></p>
<p class="MsoNormal">1001 I Street, PO Box 4025<o:p></o:p></p>
<p class="MsoNormal">Sacramento, CA 95812<o:p></o:p></p>
<p class="MsoNormal"><a href="mailto:Burke.Lucy@CalRecycle.ca.gov"><span style="color:blue">Burke.Lucy@CalRecycle.ca.gov</span></a><o:p></o:p></p>
<p class="MsoNormal">916.341.6592<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">-----Original Message-----<br>
From: pharmwaste-bounces@lists.dep.state.fl.us [mailto:pharmwaste-bounces@lists.dep.state.fl.us] On Behalf Of Tenace, Laurie<br>
Sent: Thursday, January 05, 2012 7:22 AM<br>
To: pharmwaste@lists.dep.state.fl.us<br>
Subject: [Pharmwaste] FW: Cytotoxic Chemotherapy drugs/groundwater connection</p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Forward for Marjorie Copeland at EPA<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Please take a few minutes to share your comments on the service you received from the department by clicking on this link Copy the url below to a web browser to complete the DEP survey: http://survey.dep.state.fl.us/?refemail=Laurie.Tenace@dep.state.fl.us<o:p></o:p></p>
<p class="MsoPlainText"><o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">From: Marjorie Copeland <a href="mailto:[mailto:Copeland.Marjorie@epamail.epa.gov]">
<span style="color:windowtext;text-decoration:none">[mailto:Copeland.Marjorie@epamail.epa.gov]</span></a><o:p></o:p></p>
<p class="MsoPlainText">Sent: Thursday, January 05, 2012 9:50 AM<o:p></o:p></p>
<p class="MsoPlainText">To: <a href="mailto:pharmwaste@lists.dep.state.fl.us"><span style="color:windowtext;text-decoration:none">pharmwaste@lists.dep.state.fl.us</span></a><o:p></o:p></p>
<p class="MsoPlainText">Subject: Fw: Cytotoxic Chemotherapy drugs/groundwater connection<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Hi, Everyone<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Marjorie W. Copeland<o:p></o:p></p>
<p class="MsoPlainText">Environmental Protection Agency, Mail Code 4606M Office of Ground Water and Drinking Water<o:p></o:p></p>
<p class="MsoPlainText">1200 Pennsylvania Ave. NW<o:p></o:p></p>
<p class="MsoPlainText">Washington, DC 20460-0001<o:p></o:p></p>
<p class="MsoPlainText">(202) 564-3876<o:p></o:p></p>
<p class="MsoPlainText">FAX (202) 564-3754<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Is anyone familiar with the emerging issue of cytotoxic chemotheraphy drugs contamination, if any other states besides Rhode Island and Massachusetts are focusing on related policy, or the broadness of the issue which appears to be a
specific PPCP concern? I'm also interested in finding information regarding ground water contamination from cytotoxic chemotherapy drugs.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">See email below on topic from a colleague who works for EPA Region 1 on source water protection.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Thanks,<o:p></o:p></p>
<p class="MsoPlainText">Marjorie<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">----- Forwarded by Marjorie Copeland/DC/USEPA/US on 01/05/2012 09:19 AM<o:p></o:p></p>
<p class="MsoPlainText">-----<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">From: Kira Jacobs/R1/USEPA/US<o:p></o:p></p>
<p class="MsoPlainText">To: Roy Simon/DC/USEPA/US@EPA, <a href="mailto:Copeland.Marjorie@epa.gov">
<span style="color:windowtext;text-decoration:none">Copeland.Marjorie@epa.gov</span></a><o:p></o:p></p>
<p class="MsoPlainText">Date: 01/04/2012 06:11 PM<o:p></o:p></p>
<p class="MsoPlainText">Subject: Cytotoxic Chemotherapy drugs/groundwater connection<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Roy and Marjorie,<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">I am working with my colleague Ernie Panciera at Rhode Island DEM on this emerging issue (see memo below on interpretation of Rhode Island groundwater regs). Have you heard any discussion about this issue? It seems more specific than
the broader PPCP issue.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">RIDEM asked me to check with GWPC to get the national perspective. I spoke to Mike Paque yesterday and he's going to talk to Ben G. about it when he gets back in the office.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">For now, the focus on policy seems limited to Rhode Island and Massachusetts. See bill proposed in the MA legislature this session and PowerPoint presentation given to Sen. Whitehouse (Rhode Island).<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">(See attached file: MA 2011 Bill S01089 (1).pdf)(See attached file:<o:p></o:p></p>
<p class="MsoPlainText">Pharma-Cycle_Senator.ppt)<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">The gentleman who sent me this email (Jim Mullowney) is someone who I met at the Northeast private well conference in November in CT. Jim just met with the Chairman of the EPA Science Advisory Board, Tom Zeller, last week to discuss
this.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Any insight would be appreciated!<o:p></o:p></p>
<p class="MsoPlainText">Kira<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">(See attached file: Cytotoxic Drug Contamination_Pharma_Cycle White Paper Sept 22 2011.pdf)<o:p></o:p></p>
<p class="MsoPlainText">----- Forwarded by Kira Jacobs/R1/USEPA/US on 01/04/2012 05:55 PM -----<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">From: "Jim Mullowney" <<a href="mailto:jmullowney@pharma-cycle.com"><span style="color:windowtext;text-decoration:none">jmullowney@pharma-cycle.com</span></a>><o:p></o:p></p>
<p class="MsoPlainText">To: Kira Jacobs/R1/USEPA/US@EPA<o:p></o:p></p>
<p class="MsoPlainText">Date: 11/28/2011 02:02 PM<o:p></o:p></p>
<p class="MsoPlainText">Subject: It is illegal to go to the bathroom in RI if you are on a<o:p></o:p></p>
<p class="MsoPlainText"> Cytotoxic Chemotherapy drug<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Great meeting you the other day in Southbury CT. I was the guy with the ‘Pee in a cup’ program to save the world. I would love to meet with you and your staff to discuss the topic of cytotoxic Chemotherapy drugs excreted from patients,
I know that sounds so inviting. Please read the attachment from the top environmental attorney in RI. This same legal opinion would apply with the EPA regs.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Let me know when a good time to meet is.<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
<p class="MsoPlainText">Jim(See attached file: Memorandum on Chemo drugs in urine.pdf)<o:p></o:p></p>
<p class="MsoPlainText"><o:p> </o:p></p>
</div>
</body>
</html>